The emerging treatment of the medication represents a exciting advance in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide043970.blogginaway.com/42804263/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment